Protalix BioTherapeutics, Inc. (PLX)

CIK 1006281 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Protalix BioTherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 202640001178913-26-004471
Sep 4, 202640001385113-26-000002
Sep 4, 202640001742727-26-000002
Sep 4, 202640002075661-26-000002
Sep 4, 202640001781450-26-000002
Sep 4, 202640001935668-26-000002
Sep 4, 202640001454771-26-000002
Sep 4, 202640001831558-26-000003
Sep 4, 202640001614890-26-000002
Aug 12, 20268-K0001104659-26-094433
Aug 12, 202610-Q0001104659-26-094444
Aug 12, 2026S-80001104659-26-094487
Jul 29, 2026SCHEDULE 13G0002012383-26-002863
Jun 25, 20268-K0001104659-26-077790
May 21, 20268-K0001104659-26-064850
May 13, 20268-K0001104659-26-059749
May 13, 202610-Q0001104659-26-059756
Apr 30, 2026DEF 14A0001104659-26-053016
Apr 30, 2026ARS0001104659-26-053038
Apr 27, 20263/A0001975896-26-000003
Mar 30, 2026SCHEDULE 13G/A0001426156-26-000006
Mar 18, 20268-K0001104659-26-029846
Mar 18, 202610-K0001104659-26-029858
Mar 9, 20268-K0001104659-26-024975
Mar 4, 2026SCHEDULE 13G0001426156-26-000002